V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16628130 | 330007232 | EK1PP | 3040 | X724 | 1 | 2015-11-13 | TRIAL | 330008302 | 330004033 | 330007234 |
| 16628131 | 330007232 | EJR | 400 | X724 | 1 | 2015-11-13 | ETOPOSIDE | 330008302 | 330004033 | 330007234 |
| 16628132 | 330007232 | EEI00 | 0 | X721 | 1 | 2015-11-13 | VINCRISTINE | 330008302 | 330004033 | 330007234 |
| 16628133 | 330007232 | EEI00 | 6300 | X724 | 1 | 2015-11-14 | DOXORUBICIN | 330008302 | 330004033 | 330007234 |
| 16628134 | 330007232 | EK1EN | 4450 | X724 | 1 | 2015-11-14 | FLUOROURACIL | 330008302 | 330004033 | 330007234 |
| 16628135 | 330007232 | EN201 | 1500 | X724 | 1 | 2015-11-14 | FLUOROURACIL | 330008302 | 330004033 | 330007234 |
| 16628136 | 330007233 | ECL02 | 1.4 | x724 | 1 | 2016-10-03 | ETOPOSIDE | 330008305 | 330004034 | 330007235 |
| 16628137 | 330007233 | EGQ01 | 2540 | X721 | 1 | 2016-10-03 | CETUXIMAB | 330008305 | 330004034 | 330007235 |
| 16628138 | 330007233 | EEI00 | 130 | X292 | 1 | 2016-10-10 | VINCRISTINE | 330008305 | 330004034 | 330007235 |
| 16628139 | 330007233 | EEI00 | 0 | X721 | 1 | 2016-10-10 | IFOSFAMIDE | 330008305 | 330004034 | 330007235 |
| 16628140 | 330007233 | EJR | 4560 | X721 | 1 | 2016-10-10 | DACTINOMYCIN | 330008305 | 330004034 | 330007235 |
| 16628141 | 330007233 | Haqrsvarq | 0 | null | 1 | 2016-10-10 | NOT CHEMO | 330008305 | 330004034 | 330007235 |
| 16628142 | 330007233 | EN201 | 300 | X724 | 2 | 2016-10-10 | NOT CHEMO | 330008305 | 330004034 | 330007235 |
| 16628143 | 330007234 | EE813 | 110 | X724 | 1 | 2013-03-29 | IFOSFAMIDE | 330008309 | 330010448 | 330007236 |
| 16628144 | 330007234 | EEI00 | 152 | null | 1 | 2013-03-29 | DOXORUBICIN | 330008309 | 330010448 | 330007236 |
| 16628145 | 330007234 | EGU08 | 150 | null | 1 | 2013-03-29 | MESNA | 330008309 | 330010448 | 330007236 |
| 16628146 | 330007234 | EEI00 | 0 | X721 | 1 | 2013-03-29 | IFOSFAMIDE | 330008309 | 330010448 | 330007236 |
| 16628147 | 330007234 | EK1EN | 1150 | X724 | 1 | 2013-03-29 | VINCRISTINE | 330008309 | 330010448 | 330007236 |
| 16628148 | 330007235 | EEI00 | 56 | X292 | 1 | 2017-01-10 | DACTINOMYCIN | 330008309 | 330010448 | 330007237 |
| 16628149 | 330007235 | ECL01 | 5.04 | null | 1 | 2017-01-11 | CARBOPLATIN | 330008309 | 330010448 | 330007237 |
| 16628150 | 330007235 | EKA | 100 | X724 | 1 | 2017-01-11 | ETOPOSIDE | 330008309 | 330010448 | 330007237 |
| 16628151 | 330007235 | EGU02 | 1.5 | null | 1 | 2017-01-11 | VINCRISTINE | 330008309 | 330010448 | 330007237 |
| 16628152 | 330007235 | EE813 | 185 | x724 | null | 2017-01-11 | IFOSFAMIDE | 330008309 | 330010448 | 330007237 |
| 16628153 | 330007235 | ERA20 | null | X724 | 1 | 2017-01-11 | CISPLATIN | 330008309 | 330010448 | 330007237 |
| 16628154 | 330007235 | EAF01 | 300 | null | 5 | 2017-01-11 | NOT CHEMO | 330008309 | 330010448 | 330007237 |
| 16628155 | 330007235 | EEI00 | 8500 | X723 | 1 | 2017-01-11 | FLUOROURACIL | 330008309 | 330010448 | 330007237 |
| 16628156 | 330007236 | EEI00 | 0 | X724 | 1 | 2014-03-11 | IFOSFAMIDE | 330008317 | 330004035 | 330007238 |
| 16628157 | 330007236 | ETG | 74 | X721 | 1 | 2014-03-12 | NIVOLUMAB | 330008317 | 330004035 | 330007238 |
| 16628158 | 330007236 | EEI00 | 100 | X724 | 1 | 2014-03-16 | MESNA | 330008317 | 330004035 | 330007238 |
| 16628159 | 330007236 | EEI00 | 3700 | X721 | 1 | 2014-03-17 | DACTINOMYCIN | 330008317 | 330004035 | 330007238 |
| 16628160 | 330007237 | ETG | 58 | X724 | 1 | 2017-01-11 | CYCLOPHOSPHAMIDE | 330008317 | 330004035 | 330007239 |
| 16628161 | 330007238 | ECL02 | 1.8 | X721 | 1 | 2017-07-07 | NOT CHEMO | 330008321 | 330004036 | 330007240 |
| 16628162 | 330007238 | ETG | 200 | null | 1 | 2017-07-08 | CETUXIMAB | 330008321 | 330004036 | 330007240 |
| 16628163 | 330007238 | EJRNN | 1800 | X724 | 1 | 2017-07-08 | IFOSFAMIDE | 330008321 | 330004036 | 330007240 |
| 16628164 | 330007238 | EK1PP | 280 | X721 | 1 | 2017-07-08 | ETOPOSIDE | 330008321 | 330004036 | 330007240 |
| 16628165 | 330007239 | EOF | 1.4 | null | 1 | 2017-11-13 | IFOSFAMIDE | 330008351 | 330004037 | 330007241 |
| 16628166 | 330007239 | ETG | 223 | X721 | 1 | 2017-11-13 | NOT CHEMO | 330008351 | 330004037 | 330007241 |
| 16628167 | 330007239 | EOF | 2.64 | X724 | 1 | 2017-11-13 | MULTIPLE | 330008351 | 330004037 | 330007241 |
| 16628168 | 330007239 | EE813 | 4640 | X721 | 1 | 2017-11-13 | DOXORUBICIN | 330008351 | 330004037 | 330007241 |
| 16628169 | 330007239 | EE801 | 3040 | null | null | 2017-11-13 | NOT CHEMO | 330008351 | 330004037 | 330007241 |
| 16628170 | 330007239 | EE813 | 150 | X724 | 1 | 2017-11-14 | CISPLATIN | 330008351 | 330004037 | 330007241 |
| 16628171 | 330007239 | EUZ | 1500 | X724 | 1 | 2017-11-14 | FLUOROURACIL | 330008351 | 330004037 | 330007241 |
| 16628172 | 330007239 | EW100 | 1800 | X724 | 1 | 2017-11-14 | FLUOROURACIL | 330008351 | 330004037 | 330007241 |
| 16628173 | 330007239 | EKA | 1500 | X724 | 1 | 2017-11-15 | FLUOROURACIL | 330008351 | 330004037 | 330007241 |
| 16628180 | 330007242 | EEI00 | 0.75 | null | 1 | 2014-03-27 | ETOPOSIDE | 330008365 | 330004040 | 330007244 |
| 16628181 | 330007242 | EEI00 | 150 | X721 | 1 | 2014-03-27 | AVELUMAB | 330008365 | 330004040 | 330007244 |
| 16628182 | 330007242 | EE813 | 35 | null | 1 | 2014-03-27 | NOT CHEMO | 330008365 | 330004040 | 330007244 |
| 16628183 | 330007242 | EK1PP | 4480 | null | 1 | 2014-03-27 | VINCRISTINE | 330008365 | 330004040 | 330007244 |
| 16628184 | 330007242 | EEI00 | 1500 | X724 | 1 | 2014-03-27 | DOXORUBICIN | 330008365 | 330004040 | 330007244 |
| 16628185 | 330007242 | EUZ | 8 | X721 | 1 | 2014-03-27 | NOT CHEMO | 330008365 | 330004040 | 330007244 |